HUTCHMED (00013): Donvico (TAZVERIK) has been included in the first edition of the National Commercial Health Insurance Innovative Drug Catalog.
Hwang Pharmaceuticals (0013) announced that after the renewal of medical insurance with the National Medical Insurance Administration (National Medical Insurance Bureau) in China, Elunate (ELUNATE), Orpathys (ORPATHYS), and Sulanda (SULANDA) will continue to be included in the new version of the National Basic Medical Insurance, Work Injury Insurance, and Maternity Insurance Drug List (National Medical Insurance Drug List) effective from January 1, 2026. In addition, Tazverik (TAZVERIK) has been included in the first edition of the National Commercial Health Insurance Innovative Drug List (referred to as the Commercial Health Insurance Innovation Drug List).
HUTCHMED (00013) announced that following negotiations with the National Medical Insurance Administration of China (National Medical Insurance Bureau), Elunate, Orpathys, and Sulanda will continue to be included in the new version of the National Basic Medical Insurance, Work-related Injury Insurance and Maternity Insurance Drug List (National Medical Insurance Drug List) effective from January 1, 2026. In addition, Tazverik has been included in the first edition of the National Commercial Health Insurance Innovative Drug List (referred to as the Commercial Health Insurance Innovative Drug List).
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


